# Microtransplantation Combined With Azacytidine to Improve the Efficacy of EAML

> **NCT05262465** · NA · UNKNOWN · sponsor: **guomei** · enrollment: 300 (estimated)

## Conditions studied

- Adult Acute Myeloid Leukemia

## Interventions

- **BIOLOGICAL:** microtransplantation, HLA-mismatched donor peripheral stem cell infusion
- **DRUG:** Azacitidine
- **DRUG:** Venetoclax

## Key facts

- **NCT ID:** NCT05262465
- **Lead sponsor:** guomei
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-07-01
- **Primary completion:** 2023-07-01
- **Final completion:** 2025-07-01
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2022-03-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05262465

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05262465, "Microtransplantation Combined With Azacytidine to Improve the Efficacy of EAML". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05262465. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*